Biomarker Research in Parkinson’s Disease Using Metabolite Profiling

Biomarker research in Parkinson’s disease (PD) has long been dominated by measuring dopamine metabolites or alpha-synuclein in cerebrospinal fluid. However, these markers do not allow early detection, precise prognosis or monitoring of disease progression. Moreover, PD is now considered a multifacto...

Descripción completa

Detalles Bibliográficos
Autores principales: Havelund, Jesper F., Heegaard, Niels H. H., Færgeman, Nils J. K., Gramsbergen, Jan Bert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618327/
https://www.ncbi.nlm.nih.gov/pubmed/28800113
http://dx.doi.org/10.3390/metabo7030042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618327/
https://www.ncbi.nlm.nih.gov/pubmed/28800113
http://dx.doi.org/10.3390/metabo7030042

Ejemplares similares